Arix links with LDC, Leeds Uni in metabolic projects deal
London, UK-based healthcare and life science group Arix Bioscience has signed an agreement with the Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MPI), and the University of Leeds to develop new therapeutics for metabolic diseases based on the discoveries from these organisations.
Read More
